Manuela Iadanza
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Chemical Synthesis and Analysis, Pharmacological Receptor Mechanisms and Effects, Synthesis and Characterization of Heterocyclic Compounds, Neuropeptides and Animal Physiology
Most-Cited Works
- → 2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of Selective Antagonists at Human A1and A3Adenosine Receptors Designed by 3D Database Searching(2005)48 cited
- → Design, Synthesis and Biological Evaluation of Novel N-Alkyl- and N-Acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as Novel A1 Adenosine Receptor Antagonists(2002)26 cited
- → Synthesis of (+)- and (−)-cis-2-[(1-adamantylamino)-methyl]-1-phenylcyclopropane derivatives as high affinity probes for σ1 and σ2 binding sites(2002)22 cited
- → κ-Opioid Receptor Model in a Phospholipid Bilayer: Molecular Dynamics Simulation(2002)22 cited
- → A1 adenosine receptor antagonists, 3‐aryl[1,2,4]triazino[4,3‐a]benzimidazol‐4‐(10H)‐ones (ATBIs) and N‐alkyl and N‐acyl‐(7‐substituted‐2‐phenylimidazo[1,2‐a][1,3,5]triazin‐4‐yl)amines (ITAs): Different recognition of bovine and human binding sites(2004)19 cited
- New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.(2007)
- → New results on the reactivity of 5,6‐diamino‐4‐hydroxy‐2‐mercaptopyrimidine(2004)3 cited
- → ChemInform Abstract: New Benzomorphan Derivatives of MPCB as MOP and KOP Receptor Ligands(2008)2 cited
- Real World Data e Real World Evidence: verso una nuova frontiera(2018)
- → New Results on the Reactivity of 5,6‐Diamino‐4‐hydroxy‐2‐mercaptopyrimidine.(2005)